Medicaid Alternative Payment Models for Prescription Drugs: Do They Add Value for States?
As states struggle with the increasing cost of prescription drugs, they are testing various alternative payment models (APMs). The Oklahoma Health Care Authority is a national leader with four alternative payment models in the form of direct contracts with pharmaceutical manufacturers. These contracts are each based on a specific drug, agreed-upon outcomes, and approaches to measurement. Speakers included:
- Burl Beasley, BS Pharm, MPH, MS Pharm, Director, Pharmacy Services, Medicaid Operations Division, Oklahoma Health Care Authority
- Terry Cothran, DPh, Director, University of Oklahoma College of Pharmacy, Pharmacy Management Consultants
- Russell Knoth, MA, PhD, Director, Health Economics and Outcomes, Eisai